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Introduction: To date there has been no statistical evaluation of the profiles of immunoglobulin classes 
and viral replication as variables in the study of HTLV-1 infection and circulation among families in virus-
endemic areas of Colombia. 
Objective: To evaluate the correlation of several immunological and molecular characteristics with the 
transmission and circulation of HTLV-1 among families in the town of Tumaco. 
Materials and methods: Plasma levels of HTLV-1 specific immunoglobulin classes IgG, IgM and 
IgA1, as well as IgG and sIgA in oral fluids, were calculated for 32 members of 10 family groups from 
Tumaco in which the mother and at least one child were infected with the virus. Levels of the different 
immunoglobulin classes were correlated with viral RNA circulating in plasma or oral fluids and the 
proviral burden as detected by RT-PCR. 
Results: Significant differences were determined between mothers and carrier children for 
immunoglobulin levels (p=0.037) and proviral burden (p=0.002). The overall estimate of IgG in plasma 
and sIgA in oral fluids could be correlated with the circulation of free viral RNA in both fluids and 
high proviral burden, and associated with HAM/TSP mothers. The detection of anti-tax IgG in plasma 
revealed differences between HAM/TSP mothers and their offspring. 
Conclusion: The study of immunological and molecular variables permitted the analysis of HTLV-1 
circulation among families of Tumaco. The strong correlation between levels of IgM specific for the virus 
and viral RNA circulating in fluids indirectly confirmed the transmission of HTLV-1 among families. 
Key words: Human T-lymphotropic virus, molecular epidemiology, infection, virological analysis, 
immunoglobulins.
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Evaluación serológica y virológica de la infección por el virus linfotrópico de células T humanas 
de tipo 1 en grupos familiares de Tumaco, Colombia
Introducción. Todavía no hay una evaluación estadística de los perfiles de las clases de inmuno-
globulinas y la replicación viral, como variables para estudiar la infección y la circulación del HTLV-1 
en familias de zonas endémicas en Colombia. 
Objetivo. Evaluar la correlación de varias características inmunológicas y moleculares, con la transmisión 
y circulación del virus en familias del municipio de Tumaco. 
Materiales y métodos. Se calcularon los niveles de IgG, IgM e IgA1 en plasma, e IgG y IgA secretoria 
en fluido oral, de 32 miembros de 10 grupos familiares de Tumaco, en los que la madre y, al menos, 
un hijo estaban infectados con el virus. La concentración de las diferentes clases de inmunoglobulinas 
se pudo correlacionar con la circulación de ARN viral libre en plasma y fluido oral, y la carga proviral, 
según su detección mediante reacción en cadena de la polimerasa de transcripción inversa.
Resultados. Se encontraron diferencias significativas en los niveles de inmunoglobulinas (p=0,037) 
y en la carga proviral (p=0,002) entre madres e hijos portadores. La estimación total de IgG en 
plasma e IgA secretoria en fluido oral, se pudo correlacionar con la circulación de ARN viral libre en 
ambos fluidos y una alta carga proviral, y se asoció con las madres paraparesia espástica tropical o 
mielopatía asociada con el HTLV-1. La detección en plasma de IgG anti-Tax reveló diferencias entre 
ellas y sus hijos.
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Conclusión. El estudio de las variables inmunológicas y moleculares permitió analizar la circulación 
del HTLV-1 en familias de Tumaco. La fuerte asociación entre los niveles de IgM específica para el 
virus y el ARN viral circulante en los fluidos y la carga proviral, confirmó indirectamente la transmisión 
intrafamiliar del virus. 
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Human T-cell lymphotropic virus (HTLV) type 1 was 
the first human retrovirus to be associated with 
T-cell malignancies (1,2). Infection with HTLV-1 is 
a growing worldwide health problem, with over 20 
million people estimated to be infected (3). HTLV-1 
infection is associated with a variety of human 
diseases, including an aggressive neoplastic 
disease known as adult T-cell leukemia (ATL) (4) 
and HTLV-I-associated myelopathy/tropical spas-
tic paraparesis (HAM/TSP), a chronic progressive 
inflammatory neurological disease (5). HTLV-1 
causes disease in only a small fraction of infected 
subjects, the cumulative incidence of ATL among 
HTLV-1-infected carriers being estimated as 1-5% 
for both sexes in endemic areas (6), a rate similar 
to that of HAM/TSP (7). 
An epidemiologically wide spectrum of HTLV-1-
associated diseases, including uveitis (8) and infec-
tive dermatitis in children (9) has been reported. 
Moreover, inflammatory and immune-mediated 
conditions such as polymyositis, arthropathy, 
Sjögren’s syndrome and facial nerve palsy have 
also been associated with HTLV-1 infection, 
although no clear etiological relationship has been 
established to date (10,11). 
Foci of HTLV-1 infection are found in geographical 
clusters affecting several million individuals world-
wide (12). The infection is endemic to the Caribbean 
(13), southern Japan (14), several countries of Africa, 
the Middle East, Melanesia, Papua New Guinea (15) 
and South America (16). In Colombia, as in many 
other regions of the world, HTLV-1 appears to be 
geographically concentrated on the Pacific coast, 
as well as in the Andean and Caribbean regions 
(17,18). Tumaco, a town located on the Pacific coast 
of SW Colombia, was the first area characterized 
as being endemic for HTLV-1 infection, featuring 
elevated rates of HAM/TSP (19-21). 
HTLV-1 is currently spread by sexual contact 
with an infected person, needle-sharing among 
injecting drug users or transfusions with infected 
blood. However, this last type of transmission 
route is less common in countries where blood 
is screened for HTLV-1 antibodies (22,23) or 
even blood-clotting factors (24). Mother-to-
child transmission of HTLV-1 is one of the most 
important routes of viral transmission in endemic 
areas (25), based on previous reports showing 
infection to be more prevalent among breast-fed 
than bottle-fed children. Moreover, the incidence 
of seroconversion in children who were breast-
fed over 12 months was higher than among those 
given infant formula (26,27). Although some 
studies have established the risk of transmission 
from infected mothers to offspring in family groups 
(19,28), to date there has been no statistical 
evaluation of immunoglobulin class profiles and 
viral replication among family groups in endemic 
areas of Colombia as variables to correlate HTLV-1 
infection with circulation of virus.
The main objective of the present study was 
therefore to analyze the correlation between levels 
of immunoglobulins specific for HTLV-1 in infected 
family members with detection by RT-PCR of free 
genomic RNA circulating in plasma and oral fluids, 
as well as proviral loads (PVL) in peripheral blood 
mononuclear cells (PBMC) among 10 family groups 
from Tumaco. 
Materials and methods 
The sample 
We conducted a cross-sectional study of HTLV-1 
class-specific antibody, proviral load and free RNA in 
plasma and oral fluids among family groups positive 
for HTLV-1 in Tumaco (1°48′24″N, 78°45′53″ W), 
a town of approximately 58,000 inhabitants on the 
Pacific Coast of SW Colombia. The optimal sample 
size was calculated using the Epi Info™, version 
3.5.1. Based on the above population Trujillo, et al. 
(20), previously reported the overall prevalence rate 
of HTLV-I antibodies in Tumaco as being 2.8%. 
The minimum representative sample size for the 
study was therefore 188 subjects with α = 5%. 
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For the current study, a total of 212 individuals 
belonging to several family groups in Tumaco 
were voluntarily enrolled. Peripheral blood 
samples were obtained by venal puncture. Plasma 
and PBMC were obtained using the Histopaque-
1077® gradient (Sigma-Aldrich, St. Louis, MO). 
In addition, oral fluid samples were taken using 
the FDA- approved commercial device Orasure™ 
(Epitope Inc., Beaverton, OR) according to the 
manufacturer’s instructions. 
All plasma samples were screened for HTLV 
infection by ELISA (Murex Biotech Limited, Dartford, 
UK) and were further confirmed as HTLV-1 positive 
by Western Blot (Genelabs Diagnostics Pte Ltd., 
Singapore Science Park, Singapore). Stringent 
Western Blot confirmatory criteria were applied 
and a sample was considered to be HTLV-1 
positive only if it exhibited antibodies against 
one Gag (p19 with or without p24) and two Env 
(GD21 and rgp46-I). Additionally, a PCR diagnosis 
was carried out with the pol primers SK110 (5’-
CCCTACAATCCAACCAGCTCAG-3’ (nucleotide 
4758-4779 (GenBank accession No.J02029), 
and SK111-1 (5’-GTGGTGAAGCTGCCATCGGG 
TTTT-3’, nucleotide 4947-4925) to amplify a 159 bp 
fragment DNA from PMBC DNA of the individuals 
included in the study. Only 10 of the 14 family groups 
with HTLV-1 infected members were included in 
the analysis, each of them with a mother and at 
least one offspring infected. The mothers had each 
breastfed their offspring for at least six months, but 
were not doing so at the time of sample collection. 
Immunoglobulin class detection 
The ELISA Murex HTLV I + II (Murex Biotech 
Limited, Dartford, UK) diagnostic test was used for 
screening with ratios of 1:40 for plasma and 1:5 
for oral fluids used to test every paired sample. 
Samples were incubated in 1% bovine serum 
albumin, phosphate-buffered saline (PBS) (pH7.4) 
at 42°C for 1h. Microplates were washed twice 
and incubated with goat IgG-anti IgG-, IgM (Sigma 
Chemical Co., St. Louis, MO) and sIgA (Chapel, 
Organon Teknika, West Chester, PA) at peroxidise-
labelled conjugate dilutions of 1:15,000, 1:1,000 and 
1:2,000, respectively. The procedure was carried 
out following the manufacturer’s instructions. ELISA 
OD measurements were performed in a Spectra II 
microtiter reader (Molecular Devices, Sunnyvale, 
CA); cut-offs were calculated as recommended by 
the manufacturers. The results of ELISAs with oral 
fluids samples were expressed as OD ratios (OD 
sample/OD cut-off) and normalized for salivary 
protein content. The determination of protein con-
centration in oral fluids was performed using the 
Bradford colorimetric method (Bio-Rad, Hercules, 
CA) (18). An OD ratio ≥1.1 was considered to 
be positive. 
A tax recombinant protein (29) was used to detect 
anti-tax antibodies in plasma by Western blotting. 
Screening of IgG subclass for the recombinant tax 
protein was also performed with the plasma of all 
infected family members recruited for the study. 
Western blot procedures were similar to those 
previously described by Okayama, et al. (29). 
DNA extraction and PCR protocols
High molecular weight DNA was extracted from 
PBMCs by a classical phenol-chloroform technique 
(30). DNA from subjects enrolled in the study 
was used to amplify a 1033 bp pol-env fragment 
by PCR. Each PCR reaction mixture contained 1.0 
μg of DNA, 0.2 mM deoxynucleoside triphosphate 
mix (Boehringer Mannheim, Ridgefield, CT), 10 μl 
of a 10x reaction buffer, 25 mM of each oligonucleo-
tide primer (pol SK110-1 (4773) CCATACAACCCA 
CCAGCTCAG (4794) and reverse env3 (5827) 
CCATACAACCCCACAGCTCAG (5806) and 2.5 
U of Taq DNA polymerase (Perkin-Elmer Cetus) in 
a total volume of 100 μl. Cycling conditions were: 
one cycle of 5 min at 94°C, followed by 30 cycles at 
94°C for 2 min, 55°C for 2 min, 72°C for 2 min and 
a final cycle of 72°C for 10 min. The amplification 
products were visualized by electrophoresis in a 
1.5% agarose gel (ultrapure agarose; Bethesda 
Research Laboratories). All PCR products were 
Southern blot hybridized with pMT2 DNA as an 
HTLV-1 probe. 
Extraction of RNA from plasma and oral fluids 
RNA from 200 μl of plasma and 600 μl of oral 
fluids were extracted using the QIAamp viral 
RNA mini kit (Qiagen Co., Valencia, CA) following 
the manufacturer’s instructions. The total RNA 
was suspended in 50 μl of bidestilated-diethyl 
pyrocarbonate-treated water and stored at -20°C. 
Reverse transcriptase-PCR procedures 
Amplification of HTLV-1 free genomic RNAs from 
plasma and oral fluids samples was performed 
using a thermostable DNA polymerase from 
Thermus thermophilus (Tth-DNA polymerase, 
Boerhinger Mannheim, Ridgefield, CT). cDNA 
synthesis was carried out for 30 min at 70°C in a 
reaction mix containing 10 mM Tris-HCl (pH 8.9), 
90 mM KCl (1X RT buffer), 0.9 mM MnCl, 375 μM 
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of each deoxyribonucleoside triphosphate (dNTP) 
and 750 nM of primer specific for HTLV-1 pol (SK111 
GTGGTGGATTTGC-CATCGGGTTTT) for envelope 
(env3 -CAAAAAATTGACCTGTTCCCAGT-CCTC) 
and tax (SK44 GAGCCGATAACGGCGTCCATCG), 
100 μg/ml of total plasma and salivary RNA and 
4 U of Tth DNA polymerase. The synthesized 
specific HTLV-1 cDNA was subjected to PCR in 
10 mM Tris-HCl (pH 8.9), 100 mM KCl, (1X PCR 
buffer), 1.25 mM MgCl2, 0.75 mM EDTA, and 
150 nM HTLV-1 forward primer. Sk110 primer 
(CCCTACAATCCAACCAGCTCAG positions 4757-
4778) was used to amplify a 159 bp pol fragment. 
Annealing conditions were 65°C for 45 s followed 
by an extension reaction at 72°C for 1 min. The 
pTU1 primer (CTTCGTGGACCCTCGACC positions 
5344-5366) was used to amplify a 486 bp fragment 
from the env surface domain. Annealing was per-
formed at 55°C for 45 s followed by an extension 
reaction at 72°C for 1 min. The SK 43 primer 
(GTACCGGTGGCGGTCTGG-CTT positions 7358-
7377) was used to amplify a 138 bp fragment from 
the tax gene. Annealing and extension conditions 
were the same as described for the amplification 
of 486 bp envelope fragments. All amplification 
procedures were repeated for 40 cycles. The 
amplified products were resolved by agarose gel 
electrophoresis and the respective HTLV-1 
amplified fragments determined by Southern blot 
hybridization using specific 32P-labeled oligonu-
cleotides Pol-001 (TTACTGACAAACCCGACCTA 
CCC) (4811-4824) for pol; PTU5 (GAAGTTTCA 
GCACGATGTCAATT) (5581-5603) for env, and 
PTAX5 (GACTATGTTCGGCCCGCCTACAT (7400-
7423) for tax, as probes. 
Many control experiments were performed to adjust 
not only RT-PCR conditions but the specificity of 
amplification. RNA from MT-2 cells was treated with 
RNAse or RNAse free/DNAse. No amplification of 
specific HTLV-1 gene fragments was observed with 
RNAse-treated RNA. Similar results were obtained 
with RNA from supernatants of MT-2 cell cultures 
that were submitted to the same procedure. The 
minimum amount of RNA detected by RT-PCR was 
10 pg/ml calculated from a semiquantitative RT-
PCR of RNA using the pol primers; this is equiva-
lent to approximately 100 copies of pol fragment 
per mL of sample. 
Quantification of HTLV-I proviral load 
Two sequence-specific primers that detect HTLV-I 
env region were used to amplify a 185 bp fragment 
by real-time assay. The sequences of HTLV-I env 
primers were: 5’-ATCCACTTGGCACGTCCTATA-3’ 
(5890–5910, GenBank accession Nº NC 001436) 
and 5’-GCAGGATGAGGGAGTTATGTC-3’ (6054–
6074). The dual-labeled fluorescent probe was FAM 
-5’-CTTTACCCATCGTTAGCGCTTCCAGCCCCC-
3’-BHQ1 (5954–5983). In order to determine 
the amount of cellular human beta-globin DNA 
as internal amplification control of differences in 
PBMC count and DNA extraction, all samples 
were run in parallel. A 187 bp fragment of beta-
globin gene was amplified by forward primer 
5’-GGTATCCTTTTTACAGCA CAA C-3’ and 
reverse primer 5’-CAGGTCCCCAAAGGACTC 
G-3’ in a real-time PCR assay. The fluorogenic 
probe used to detect the β-globin gene was 5’-
CCTGGGCTGTTTTCATTTTCTCAGG-3, BHO-2 
(471-495) (Biosearch Technologies Inc., Novato, 
CA). To determine the sensitivity for this assay, 
scalar dilutions of pMT2 clone DNA ranging from 1 
to 109 copies were analyzed. The results indicated 
that a positive signal was consistently detected at 
HTLV-1 DNA concentrations above 1 copy per ng 
of DNA. Based on these results, the limitation of 
this assay was considered to be 1 copy of HTLV-1 
proviral DNA per nanogram of genomic DNA. 
HTLV-1 env and beta-globin gene fragments were 
amplified separately in a Mx3000P Real-Time PCR 
System (Stratagene, La Jolla, CA) in 50 μl reaction 
mix of 10 μl of DNA sample, 25 μl of Brilliant QPCR 
Master Mix (containing PCR buffer, SureStart Taq 
DNA polymerase) (Stratagene, La Jolla, CA), 10 
pmol of each primer, and 5 pmol of TaqMan probe. 
Thermal cycling conditions were as follows: 95°C 
for 10 min followed by 45 cycles of 95°C for 30 s, 
55°C for 1 min and 72°C for 30 s. Each sample was 
analyzed in duplicate. The HTLV-1 proviral load 
(PVL) was calculated as the copy number of each 
per ng of genomic DNA. 
Statistical analysis 
Data analyses were performed with the Stata-
graphics package (Centurion XVI Inc.). A significant 
sample size was calculated with Epi Info™, version 
3.5.1 software. The Fisher exact test was applied 
to estimate statistical differences among HAM/
TSP, AC, sex, age and immunoglobulin class and 
subclass values. A non-parametric Mann-Whitney 
test was used to evaluate the average levels of 
immunoglobulin class and proviral load between 
mothers and their offspring. Linear regression 
was applied to calculate the correlation coefficient 
values between immunoglobulin class levels in 
plasma and oral fluids with proviral load. 
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The following expression was used to calculate 
the General Vertical Transmission (GVT) rate: 
GVT= [Number of seropositive offspring / Total of 
offspring of the sample] x [Serum prevalence] 
Based on previous data from Trujillo, et al. (20), the 
HTLV-1 serum prevalence among inhabitants of 
Tumaco is 2.8%. 
Ethical considerations 
The study protocol was approved by the Ethics 
Committee of the Universidad del Valle in 
agreement with the guidelines of World Medical 
Association Declaration of Helsinki and Resolution 
008430/1993 of the Colombian Ministry of Health. 
All adult participants (or, in the case of children, their 
parents) were informed about the purpose of the 
study and gave their consent to use the collected 
samples only for research under a guarantee of 
remaining anonymous. 
Results 
Characteristics of the family groups 
All 46 (21.7%) of the 212 participants in the study 
were confirmed as being HTLV-1 seropositive with 
16 of them (34.8%) clinically diagnosed as HAM/
TSP patients. The mean number of offspring per 
family was 3.4 ± 2.2. Fourteen families had at 
least one member infected with HTLV-I and 19/69 
offspring were HTLV-1 seropositive, corresponding 
to a GVT rate of 0.66% [0.55-0.77].
Ten (71.4%) families that met the criteria previously 
cited (an infected mother and at least one HTLV-1 
seropositive offspring) were studied. Family relation-
ships, age and ethnic background are documented 
in table 1. The mean age for HTLV-1 infected 
mothers was 45.4 ± 7.02 years old and that of 
offspring was 12.4 ± 5.05 years. The mean age of 
infected members per family corresponded to 3.26 
± 1.2 and the ratio of offspring per infected mother 
was 1.7. Four of the families had HAM/TSP mothers 
(mean age, 47.7 ± 4.9 years old); only one young 
man aged 15 in family 2 had a preliminary diagnosis 
of HAM/TSP; the remaining offspring were clinically 
classified as asymptomatic (table 1). 
Immunoglobulin class and subclass 
As it is shown in figure 1A, only the HAM/TSP 
mothers showed higher levels of IgG (p<0.001), 
IgM (p<0.001) and IgA1 (p<0.005) in plasma 
in comparison with asymptomatic mothers and 
offspring. Only one asymptomatic young male 
of family 1 exhibited increased levels of IgM and 
IgA1 in plasma. These levels contrasted with the 
findings for the 15 year-old male of family 2 who 
had a preliminary diagnosis of HAM/TSP but no 
IgM and IgA1 in his plasma. 
When the immunoglobulin class levels in oral fluids 
were studied it was possible to observe significant 
differences for IgG (p<0.001) and sIgA (p<0.001) 
between HAM/TSP mothers and their asympto-
matic offspring (figure 1A). It was interesting to note 
that the asymptomatic mothers of families 5 and 9 
showed HTLV-1 specific IgG in oral fluids. Anti-tax 
antibodies were detected in the plasma of 100% 
of the infected mothers but only in 12/17 (70.5%) 
of descendants (p<0.05). The mean age of anti-
tax reactive offspring was 11.1 ± 3.6 years. Anti-
tax IgG1 was recorded in all tax-reactive plasma 
samples; however, an extra reaction of anti-tax 
IgG3 antibodies could only be detected in HAM/
TSP mothers. Statistically significant differences in 
the median levels of IgG in plasma were recorded 
between mothers and their offspring (Mann-Whitney 
test; p=0.037) (figure 2A). 
Free HTLV-1 RNAs templates in plasma and 
oral fluids 
Free HTLV-1 RNA templates for pol, env and tax 
were detected in plasma samples of all HAM/
TSP mothers; these results contrasted with those 
for most asymptomatic HTLV-1 positive mothers 
except for the one of family 5 (table 2). The situation 
in asymptomatic offspring was similar to that of 
asymptomatic mothers, with the exception of a 15 
year-old youth with a preliminary diagnosis of HAM/
TSP who had a similar pattern to those of HAM/
TSP mothers (table 2).
The oral fluids of all HAM/TSP mothers and the 
young male from family 2 amplified free HTLV-1 
RNAs templates for pol, env and tax; in contrast, 
the asymptomatic mothers and their offspring did 
not reveal any genomic RNA circulating in their oral 
fluids (table 2). 
Proviral load correlation with IgG and IgM levels 
in plasma 
The PVL values for all individuals included in this 
study are shown in figure 1B (median of 4.56), 
illustrating the wide range of PVL values, with the 
highest corresponding to HAM/TSP mothers. The 
mean PVL calculated in PBMC for the mothers 
was 7.78 ± 6.45 copies/ng DNA vs. 2.63 ± 1.84 
for their offspring (p<0.001). Only the 15 year-old 
of family 2 with the preliminary diagnosis of HAM/
TSP had a PVL value of 9.0 copies/ng DNA. The 
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differences between the proviral loads of mothers 
and their offspring were statistically significant 
(Mann-Whitney test, p=0.002) (figure 2B). 
Several correlation analyses were performed be-
tween pairs of variables in the study. As shown in 
table 3 the highest values were recorded for IgG vs. 
PVL and IgM vs. IgA1 in plasma. A positive regression 
model between IgG plasma levels and PVL provided 
the linear equations IgG= 0.6461 + 0.0873 x PVL 
(r=0.90; p<0.001) (table 3). The linear equation for 
IgM vs. IgA1 in plasma was IgM Plasma=-0.0245122 
+ 0.964651 x IgA1 Plasma (r=0.95; p<0.001). 
Discussion 
We studied the associations between several 
serological and molecular biological characteristics 
during HTLV-1 transmission from mother to child. 
Table 1. Base line information of HTLV-1 infected members of different family groups from Tumaco, Colombia 
Family Member’s status Family relationship Age (years) Sex Ethnic background (**) RIF (percentage) (***)
1
*N=4
2
*N=4
3
*N=3
4
*N=3
5
*N=3
6
*N=3
7
*N=3
8
*N=5
9
*N=4
10
*N=3
HAM/TSP
AC
AC
AC
HAM/TSP
AC
HAM/TSP
AC
AC
HAM/TSP
AC
HAM/TSP
AC
AC
AC
Negative
AC
AC
AC
HAM/TSP
AC
AC
AC
AC
HAM/TSP
AC
AC
AC
AC
AC
HAM/TSP
AC
AC
AC
AC
AC
Mother
Son
Son
Son
Mother
Daughter
Son
Son
Mother
Father
Son
Mother
Father
Daughter
Mother
Father
Son
Daughter
Mother
Father
Son
Mother
Father
Daughter
Mother
Father
Daughter
Son
Daughter
Mother
Father
Son
Grandfather
Mother
Father
Son
54
  8
13
15
47
  9
15
20
53
54
10
48
48
16
39
45
  8
16
48
51
13
48
42
  6
42
47
  3
  9
13
45
56
21
61
30
28
  8
F
M
M
M
F
M
M
F
M
M
F
M
F
F
M
M
F
F
M
M
F
M
F
F
M
F
M
F
F
M
M
M
F
M
M
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
3/5
(60.0%)
3/4
(75.0%)
1/2
(50.0%)
1/3
(33.3%)
1/3
(33.3%)
1/3
(33.3%)
1/3
(33.3%)
3/3
(100%)
1/1
(100%)
1/1
(100%)
* N: Number of family members infected with HTLV-1; AC: Asymptomatic carrier; HAM/TSP: HTLV-I-associated myelopathy/tropical spastic 
paraparesis; **: 1, African American, 2, Mestizo; ***: Ratio of infected per family; RIF: Number of infected offspring/Total offspring; F: Female; M: Male
Our results support the existence of a significant 
correlation between detectable levels of HTLV-1 
specific IgM in plasma and sIgA in oral fluids with 
PVL in PBMC from HAM/TSP mothers included 
in the study. Moreover, differences were also 
recorded between sIgA levels in oral fluids, as well 
as for RT-PCR data between HAM/TSP patients 
and AC. These results provided strong evidence 
that HTLV-1 infection in the oral cavity was not 
restricted to the oral mucosa cells of HAM/TSP 
mothers and their asymptomatic offspring. Our 
data also revealed vertical transmission via oral 
mucosa from mothers to their offspring in a sample 
of seropositive family members from Tumaco. 
Previous reports showed an association of the 
presence in HAM/TSP patients of free genomic 
HTLV-1 RNAs with an active production of sIgA in 
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oral fluids and viral mRNA transcription in epithelial 
cells of oral mucosae (31,32). Thus the differences 
recorded between HAM/TSP mothers and asympto-
matic carriers in the mucosal associated response 
suggest that both immunological and cellular 
changes occur during progression to disease. 
The immune status of HAM/TSP mothers included 
in the current study, with anti-HTLV-1 IgG in plasma 
and sIgA in oral fluids, as well as free viral RNA 
templates in saliva, suggest that HTLV-1 infection of 
epithelial targets could possibly occur by cell-to-cell 
contact with HTLV-1 infected oral fluids lymphocytes 
or during breastfeeding. However, it remains to be 
determined whether those lymphocytes circulate for 
longer in saliva or are newly deposited in saliva and 
milk by leaking from microcirculation as has been 
reported previously (32-35). There is some indirect 
evidence, both from our own study and previous 
work for HTLV-1 infection of oral mucosa by cell-
to-cell contact with circulating T cells, primarily 
through breast-feeding (32,36-38). 
Although our results indirectly showed active 
infection of oral mucosa to be correlated with an 
active immune process via specific anti-tax HTLV-1 
sIgA, there still remains the question of whether 
oral fluids and/or saliva really are infective. There is 
some evidence to indicate that inoculation of salivary 
gland cells and cell-free saliva from healthy carriers 
and patients with HAM/TSP into WKA and F344 
female rats does produce a successful infection, 
as confirmed by nested PCR from inoculated rat 
DNA, HTLV-1 proviruses in PBMC, spleen, thymus, 
salivary glands, spinal cord, kidney and brain (39). 
Anti-tax IgG1 was recorded in all tax-reactive 
plasma samples; however, an extra reaction of 
anti-tax IgG3 antibodies could only be detected 
in HAM/TSP mothers. In general, anti-viral IgG 
antibodies are highly restricted to IgG1 and IgG3; 
however, IgG3 antibodies appear first in the course 
of infection and are associated with inflammation. 
The proviral load with tax may affect cellular genes 
such as cytokines and oncogenes, besides being 
involved in pathogenicity. A significant increase 
of tax expression was observed in PBMCs of 
HAM/TSP patients compared to healthy carriers, 
this being associated with PVL in patients (40). 
Although proviral load has been considered as a 
valuable parameter for monitoring HTLV-1 infected 
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Figure 1. Immunoglobulin class and proviral load values 
in HTLV-1 seropositive subjects from Tumaco. (A). Levels of 
HTLV-1 specific IgG, IgM and IgA1 in plasma and IgG and 
sIgA in oral fluids. Cut off points were calculated according to 
manufacturers’ instructions: IgG plasma = 0.080; IgM plasma 
= 0.15; IgA1= 0.12. ELISA values for oral fluids were expressed 
as OD ratios. IgG OF O.D= 1.1 and sIgA OF OD= 1.3. (B). 
Distribution of PVL values in PBMC DNA of seropositive subjects 
from Tumaco. Bold gray squares represent TSP/HAM mothers.
Figure 2. Differences in serological and molecular characteristics 
among seropositive mothers and their offspring in family groups 
of Tumaco. (A). HTLV-1-IgG specific. (B). Proviral load values. p 
values were calculated by a Man and Whitney test. 
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Table 2. Detection of pol fragment by PCR and free genomic RNA for pol, env and tax by RT-PCR in plasma and oral fluids in HTLV-1 
seropositive members of family groups from Tumaco
PCR RTPCR
Family Members Plasma  Oral fluids
Pol Pol Env Tax Pol Env Tax
  1
  2
  3
  4
  5
  6
  7
  8
  9
10
HAM/TSP*
AC**
AC
AC
HAM/TSP*
AC**
HAM/TSP
AC
AC*
HAM/TSP**
AC
HAM/TSP*
AC**
AC
AC*
Negative**
AC
AC
AC*
HAM/TSP**
AC
AC*
AC**
AC
HAM/TSP*
AC**
AC
AC
AC
AC*
HAM/TSP**
AC
AC
AC*
AC**
AC
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
-
+
-
-
-
+
-
-
+
-
-
+
-
-
+
-
+
-
-
+
-
+
-
-
-
-
-
+
-
-
-
+
-
+
-
+
-
+
-
-
-
+
-
-
+
-
-
+
-
-
-
-
+
-
-
+
-
+
-
-
-
-
-
+
-
-
-
+
-
+
-
+
-
+
-
-
-
+
-
-
+
-
-
+
-
-
-
-
+
-
-
+
-
+
-
-
-
-
-
+
-
-
-
+
-
+
-
+
-
+
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+
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+
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+
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+
-
+
-
-
-
-
-
-
+
-
-
+
-
-
-
-
+
-
-
+
-
+
-
-
-
-
-
+
-
-
-
-
-
 *: Mothers; **: Fathers; +: Detection by PCR and RT-PCR of amplicons and confirmation by Southern blot hybridization; -: No detection
Table 3. Spearman’s rho correlation coefficient values between pairs of immunoglobulin class-specific and HTLV-1 in plasma and 
oral fluids or proviral load in seropositive DNA PBMC of individuals from Tumaco
IgG in plasma IgM in plasma IgA1 in plasma IgG in oral fluids sIgA in oral fluids Proviral load
IgG in plasma
IgM in plasma
IgA1 in plasma
IgG in oral fluids
sIgA in oral fluids
Provaral load
-
0.76
0.73
0.84
0.72
0.90
-
0.95
0.82
0.87
0.85
-
0.82
0.83
0.86
-
0.82
0.78
-
0.67 -
 Values in bold numbers are statistically significant (95%). 
subjects, previous studies have demonstrated 
that tax expression in activated PBMCs and 
proviral load assessment in HAM/TSP patients 
were more reliable in determining prognoses as 
well as monitoring healthy carriers and HAM/TSP 
patients (40).
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Transmission of HTLV-1 within families has been 
documented in different epidemiological studies 
carried out in several endemic areas around the 
world (41-43). However, the study reported here is 
the first in Colombia to follow up HTLV-1 infection 
dynamics in family clusters using immunological, 
virological and molecular markers. The results 
are important given that Colombia has many 
HTLV-1 endemic areas. Our data suggest that 
viral transmission may occur when mothers have 
active infections while breastfeeding their children. 
Although none of the mothers in the study were 
breastfeeding at the time samples were collected, 
the detection of virus in plasma and oral fluids 
and the high proviral load in lymphocytes pro-
vided strong evidence for a correlation with viral 
gene expression in cells, particularly those of the 
oral epithelium. 
Many HTLV-1 infected individuals in Colombia 
live below the poverty line in areas with poor 
health facilities. Since measurement of proviral 
load for HTLV-1 is an expensive and time-
consuming process, affordable laboratory tests 
need to be developed and applied to evaluate 
not only immunoglobulin class disturbance but 
also to follow up virus transmission among family 
groups. The results of the present study lead us to 
the conclusion that quantificationS by ELISA of 
HTLV-1 IgG and IgM in plasma are procedures 
that allow prognoses to be made of the replication 
status of the infected individuals instead of PVL. 
The evaluation of those serological variables is 
crucial to performing public health surveillance of 
virus circulation in families, particularly in areas 
that are highly endemic for HTLV-1. 
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